A retrospective study optimal administration frequency Pembrolizumab-Based Regimens Administered in patients with non-small cell lung cancer
Latest Information Update: 16 Oct 2019
At a glance
- Drugs Pembrolizumab (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 16 Oct 2019 New trial record
- 10 Sep 2019 Results presented at the 20th World Conference on Lung Cancer